Study gut leakiness in obesity and fatty liver with a ketogenic diet
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at “gut permeability,” sometimes called intestinal leakiness, in people with obesity and fatty liver disease. It tests whether a ketogenic (very low-carb) diet changes gut leakiness and fatty liver measurements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old, and you can be any sex
- You have obesity (BMI 30 or higher) OR abdominal fat (waist over 94 cm for men, over 80 cm for women)
- You have fatty liver confirmed by FibroScan (CAP over 238 dB/m), plus other liver risk scores if needed
- You are not pregnant and not breastfeeding
- You are not taking treatments/devices (or other therapies) that could change gut leakiness or liver fat
- You do not have other conditions that could also explain changes in gut leakiness or fatty liver
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study looks at how metabolism works in children and teens who have (or do not have) nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. Participants may include healthy-weight controls, obese controls without NAFLD, and kids with NAFLD who are already scheduled for a liver biopsy for clinical reasons.
This study tests how “lipid” (fat) changes in the body affect insulin resistance, which is when the body doesn’t respond to insulin as well as it should. Because it’s done in healthy people, it’s mainly looking at basic biology and may help guide future treatments.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study tests whether intermittent fasting combined with a Mediterranean diet can help people with moderate to severe non-alcoholic fatty liver disease (NAFLD) improve their liver health. If you are overweight and have been diagnosed with NAFLD, this trial may offer a dietary approach to manage your condition.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.